Desktop Genetics Ltd Raises £1.37 Million GBP ($2.15M USD) Funding
This latest round of investment will enable Desktop Genetics to commercialize its proprietary DESKGEN genome…read more
The DESKGEN platform makes CRISPR gene editing more predictable, accessible and efficient, arming scientists with all of the capabilities they need to scale their genomics research. Users are walked through every step of the CRISPR gene editing process with a suite of lab-validated algorithms derived from leading peer-reviewed research and industry expertise.
In addition to enhancing researchers’ productivity and reducing the time and cost of gene editing with software tools, DTG also offers CRISPR library design, synthesis and screening services, and is partnering with specialist companies to create a high-throughput cell line engineering service in the cloud.
Associated Fund Rainbow Seed Fund
Sector Medical / Biotechnology